Before assignment: who gets enrolled?
Imagine a fictional trial with a predictable sequence of assignments. If a recruiter knows the next person will receive a preferred option, that knowledge could influence who is enrolled next or when enrollment occurs.
A concealed allocation process prevents that foreknowledge. Simply describing the sequence as random is insufficient if the next assignment can be inspected or predicted.
After assignment: who knows what happened?
Once participants receive an intervention, knowledge of the assignment may influence behavior, co-interventions, reporting, or outcome assessment. Blinding can address some of those pathways.
For a comparison of two visibly different exercise programs, participants may know which program they attend. An assessor measuring an outcome might still be kept unaware of the assignment. “Unblinded study” therefore needs more detail about which people knew and which outcome is being considered.
Put the protections on a timeline
- Generate an assignment sequence.
- Conceal future assignments during enrollment.
- Assign the participant.
- Limit knowledge after assignment where feasible and useful.
The sequence makes clear why concealment and blinding are not synonyms. Cochrane's risk-of-bias guidance distinguishes these mechanisms rather than treating a single label such as “double blind” as a complete description.
What to look for in the report
A useful paper explains who generated the sequence, how assignments were implemented, who was unaware of them, and how outcomes were assessed. If blinding was impossible, the report can describe measures used to reduce relevant bias.
Lack of blinding is not an automatic verdict that every outcome is invalid. The assessment depends on the pathway by which knowledge could affect that particular result. Naming the people and timing makes the concern specific enough to evaluate.
